Know Labs Inc
AMEX:KNW
Know Labs Inc
Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. The company is headquartered in Seattle, Washington and currently employs 12 full-time employees. The company went IPO on 2006-04-12. The firm offers technology that uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The firm offers a technology called Bio-RFID, which identifies and provides the user with real-time information on their blood glucose levels. Bio-RFID can be integrated into a variety of wearable, mobile or bench-top form factors. Bio-RFID uses radio waves to identify and measure what is going on inside the body. The firm offers UBAND, which is a wearable non-invasive glucose monitor that measures blood glucose levels without fingerpricks or needles. The company helps people with diabetes and pre-diabetes manage their conditions. UBAND’s Bio-RFID sensor detects molecular signatures in other substances such as oxygen, alcohol, and metabolized drugs. Its user can subscribe to multiple monthly services for medical reasons and others lifestyle.
Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. The company is headquartered in Seattle, Washington and currently employs 12 full-time employees. The company went IPO on 2006-04-12. The firm offers technology that uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The firm offers a technology called Bio-RFID, which identifies and provides the user with real-time information on their blood glucose levels. Bio-RFID can be integrated into a variety of wearable, mobile or bench-top form factors. Bio-RFID uses radio waves to identify and measure what is going on inside the body. The firm offers UBAND, which is a wearable non-invasive glucose monitor that measures blood glucose levels without fingerpricks or needles. The company helps people with diabetes and pre-diabetes manage their conditions. UBAND’s Bio-RFID sensor detects molecular signatures in other substances such as oxygen, alcohol, and metabolized drugs. Its user can subscribe to multiple monthly services for medical reasons and others lifestyle.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
